The national blueprint for future factor VIII inhibitor clinical trials: NHLBI State of the Science (SOS) Workshop on factor VIII inhibitors
出版年份 2019 全文链接
标题
The national blueprint for future factor VIII inhibitor clinical trials: NHLBI State of the Science (SOS) Workshop on factor VIII inhibitors
作者
关键词
-
出版物
HAEMOPHILIA
Volume 25, Issue 4, Pages 581-589
出版商
Wiley
发表日期
2019-07-22
DOI
10.1111/hae.13717
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The national blueprint for 21st century data and specimen collection and observational cohort studies: NHLBI State of the Science Workshop on factor VIII inhibitors
- (2019) Barbara A. Konkle et al. HAEMOPHILIA
- Registry Contributions to Strengthen Cell and Gene Therapeutic Evidence
- (2018) Mohamed Abou-El-Enein et al. MOLECULAR THERAPY
- Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
- (2018) Johnny Mahlangu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
- (2017) Lindsey A. George et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emicizumab Prophylaxis in Hemophilia A with Inhibitors
- (2017) Johannes Oldenburg et al. NEW ENGLAND JOURNAL OF MEDICINE
- AAV5–Factor VIII Gene Transfer in Severe Hemophilia A
- (2017) Savita Rangarajan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Embedding clinical interventions into observational studies
- (2016) Anne B. Newman et al. Contemporary Clinical Trials
- Disease-specific clinical trials networks: the example of cystic fibrosis
- (2016) Kris De Boeck et al. EUROPEAN JOURNAL OF PEDIATRICS
- Impact of inhibitors on hemophilia a mortality in the United States
- (2015) Christopher E. Walsh et al. AMERICAN JOURNAL OF HEMATOLOGY
- Emerging innovations in clinical trial design
- (2015) DA Berry CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Master Protocol Concept
- (2015) Mary W. Redman et al. SEMINARS IN ONCOLOGY
- Joint WFH-ISTH session: issues in clinical trial design
- (2014) F. Peyvandi et al. HAEMOPHILIA
- Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
- (2014) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Design of the INHIBIT trial: preventing inhibitors by avoiding ‘danger’, prolonging half-life and promoting tolerance
- (2014) Margaret V Ragni et al. Expert Review of Hematology
- Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
- (2013) S. C. Gouw et al. BLOOD
- Use of historical control data for assessing treatment effects in clinical trials
- (2013) Kert Viele et al. PHARMACEUTICAL STATISTICS
- Challenges of rare disease research: limited patients and competing priorities
- (2011) M. V. RAGNI et al. HAEMOPHILIA
- Survey of current prophylaxis practices and bleeding characteristics of children with severe haemophilia A in US haemophilia treatment centres
- (2011) M. V. RAGNI et al. HAEMOPHILIA
- Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapy
- (2010) J. D. Finn et al. BLOOD
- Clinical trials and haemophilia: does the Bayesian approach make the ideal and desirable good friends?
- (2009) A. IORIO et al. HAEMOPHILIA
- Ethical considerations in clinical investigation: exploring relevance in haemophilia research
- (2008) D. M. DIMICHELE HAEMOPHILIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started